Home
About BEB
Curriculum
Admission
CNC Research
BEB in the Media
 
 
MIT - Principles and Practice in Drug Development
 
January 21 - February 1
João Nuno Moreira - jmoreira@ff.uc.pt, Luís Almeida, Sérgio Simões

MIT-PT PROGRAMME 2012/2013
PRINCIPLES AND PRACTICE IN DRUG DEVELOPMENT - ELECTIVE COURSE
Center for Neuroscience and Cell Biology (CNC) - University of Coimbra

January 21-February 1, 2013
João Nuno Moreira, Luís Pereira de Almeida, Sérgio Simões, Stan Finkelstein
Local: CNC auditorium (Polo 1)



January 21 - Monday

10.00 h - Introduction to the course
João Nuno Moreira PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Luís Pereira de Almeida PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Sérgio Simões PhD (CNC and Faculty of Pharmacy, University of Coimbra)
Stan N. Finkelstein MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

11.00 h - The Pharmaceutical Industry and the Drug Development Process
Stan N. Finkelstein MD, PhD (Senior Research Scientist in the MIT Engineering Systems Division and Associate Professor of Medicine, Harvard Medical School)

16.00 h - Basic Science I – Discovery Innovation and Emerging Technologies; Basic Business
Anthony J. Sinskey PhD (Professor of Biology at MIT)

January 22 - Tuesday

10.00 h - Modeling chemistry and biology in drug discovery
Nuno Palma PhD (BIAL, Indústria Farmacêutica, Portugal)

11.30 h - Clinical development of new chemical entities
Nélson Lopes PharmD, MD (BIAL, Indústria Farmacêutica, Portugal)

14.30 h - Development of small molecule inhibitors for treatment of CNS disorders
Laszlo Kiss PhD (BIAL, Indústria Farmacêutica, Portugal)

16.00 h - Pharmacology and toxicology of new chemical entities
Lyndon C. Wright PhD (BIAL, Indústria Farmacêutica, Portugal)

January 23 - Wednesday

9.00 h - FDA Process, Off-Label Prescribing, Insurance Coverage
Stan N. Finkelstein MD, PhD (Senior Research Assistant in the MIT Engineering Systems Division and Associate Professor of Medicine at Harvard Medical School)

January 24 - Thursday

10.00 h - Regulatory Affairs – the european perspective
Rogério Gaspar PhD (iMed.UL and Faculty of Pharmacy, University of Lisbon)

16.00 h - Technology transfer – the perspective from MIT
Tom Tachovsky (Licensing officer at the MIT TLO)

January 25 – Friday

9.00 h - Visit to Biocant Park – Innovation Center in Biotechnology

14.30 h - Photodynamic therapy in oncology
 Luís Arnaut PhD (CSO of Luzitin, SA)

16.00 h - Building Merrimack Therapeutics
Robert Mulroy CEO of Merrimack Therapeutics

January 28 - Monday

10.00 h - Some issues in drug development: discussion of case studies
Miguel Prazeres PhD (Instituto Superior Técnico, Technical University of Lisbon)

15.00 h - The Pharmaceutical Industry in the 21st century
Guy Villax CEO of Hovione

January 29 - Tuesday

9.30 h - Nanotechnology for drug and gene targeting and the impact on drug development
Sérgio Simões PhD
João Nuno Moreira PhD
Luís Pereira de Almeida PhD

14.30 h - Bluepharma Pharmaceutical Industry SA: from development of generics to innovative research - site visit

January 30 - Wednesday

10 h - Manufacturing and quality by design in the pharmaceutical industry
Rui Loureiro PhD
Chemist - Hovione

14.00 h - BIOALVO – A story of entrepreneurial learning in the drug discovery path
Helena Vieira PhD (CEO BIOALVO SA)

16.00 h - Building more predictive in vitro and in vivo models to identify responder populations preclinically
Darrin Stuart PhD
Senior Investigator II
Novartis Institutes for Biomedical Research

January 31 – Thursday

9 h - Students presentations

 

 

back
 
© 2017 BEB - Doctoral Programme in Experimental Biology and Biomedicine powered by ponto.C